IPJSC Lenta dr Financial Statements (LENT) |
||||||||||
Лентаsmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
---|---|---|---|---|---|---|---|---|---|---|
Report date | 25.02.2020 | 24.02.2021 | 21.02.2022 | 29.03.2023 | 21.03.2024 | 30.07.2024 | ||||
Currency | RUB | RUB | RUB | RUB | RUB | RUB | ||||
Financial report URL | ||||||||||
Annual report URL | ||||||||||
Presentation URL | ||||||||||
Number of stores, pcs. | 380 | 393 | 757 | 820 | 2 819 | 3 155 | ||||
New stores opened, pcs. | 1 | 13 | 364 | 0 | ||||||
Stores square, thousand m2 | 1 489 | 1 519 | 1 755 | 1 788 | 2 325 | 2 358 | ||||
Like for like sales, % | ? | 0.1% | 5.4% | 2.4% | 2.3% | 4.6% | 14.6% | |||
Traffic, % | 0.0% | -5.5% | -2.1% | -2.6% | 2.0% | 5.1% | ||||
Average check, % | 0.1% | 11.6% | 4.7% | 5.0% | 2.6% | 9.1% | ||||
Average check, rub | 998 | 1 115 | 1 092 | |||||||
Online Sales, bln rub | 0.9 | 6.3 | 19.3 | 12.7 | ||||||
Share of online sales, % | 0% | 1% | 4% | 9% | ||||||
Number of orders, mln | 0.4 | 3.3 | 10.5 | 6.5 | ||||||
Revenue, bln rub | ? | 417.5 | 445.5 | 483.6 | 537.4 | 615.9 | 772.4 | |||
Operating Income, bln rub | 19.3 | 24.6 | 23.2 | 14.4 | 13.9 | 31.0 | ||||
EBITDA, bln rub | ? | 34.0 | 39.3 | 39.2 | 32.6 | 33.6 | 54.6 | |||
Net profit, bln rub | ? | -2.10 | 17.4 | 13.6 | 4.85 | -0.930 | 13.1 | |||
OCF, bln rub | ? | 31.1 | 27.3 | 33.6 | 20.2 | 41.7 | 57.7 | |||
CAPEX, bln rub | ? | 14.0 | 7.41 | 30.8 | 10.2 | 11.1 | 18.6 | |||
FCF, bln rub | ? | 17.1 | 19.9 | 2.10 | 10.0 | -43.0 | -32.9 | |||
Ordinary share dividend yield, % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | ||||
Dividend payout ratio, % | 0% | 0% | 0% | 0% | 0% | 0 | ||||
OPEX, bln rub | 76.5 | 81.5 | 93.1 | 113.0 | 122.7 | 144.3 | ||||
Cost of production, bln rub | 325.8 | 344.1 | 372.5 | 416.7 | 486.3 | 605.2 | ||||
Amortization, bln rub | 14.7 | 14.7 | 16.1 | 18.2 | 19.6 | 22.5 | ||||
Employment expenses, bln rub | 28.1 | 31.3 | 35.4 | 44.2 | 48.2 | 59.6 | ||||
Interest expenses, bln rub | 9.26 | 6.22 | 4.92 | 4.92 | 6.64 | |||||
Assets, bln rub | 295.7 | 247.6 | 288.0 | 348.0 | 462.2 | 448.4 | ||||
Net Assets, bln rub | ? | 80.1 | 97.3 | 111.0 | 135.2 | 126.9 | 136.8 | |||
Debt, bln rub | 150.5 | 79.0 | 88.4 | 81.1 | 139.9 | 133.9 | ||||
Cash, bln rub | 73.4 | 21.8 | 33.3 | 29.0 | 44.5 | 41.5 | ||||
Net debt, bln rub | 77.1 | 57.1 | 55.1 | 52.1 | 95.4 | 92.4 | ||||
Ordinary share price, rub | 192.0 | 262.9 | 998.0 | 691.0 | 670.5 | 1 041 | ||||
Number of ordinary shares, mln | 487.9 | 487.9 | 97.6 | 116.0 | 116.0 | 116.0 | ||||
Free Float, % | 21.0% | 21.0% | 17.0% | 21.0% | ||||||
Market cap, bln rub | 93.7 | 128.3 | 97.4 | 80.1 | 77.8 | 120.7 | ||||
EV, bln rub | ? | 170.8 | 185.4 | 152.5 | 132.2 | 173.1 | 213.1 | |||
Book value, bln rub | 77.8 | 94.7 | 107.9 | 129.9 | 126.9 | 136.8 | ||||
EPS, rub | ? | -4.31 | 35.8 | 139.8 | 41.8 | -8.02 | 112.5 | |||
FCF/share, rub | 35.0 | 40.7 | 21.5 | 86.6 | -370.7 | -283.7 | ||||
BV/share, rub | 159.5 | 194.1 | 1 106 | 1 120 | 1 094 | 1 179 | ||||
EBITDA margin, % | ? | 8.1% | 8.8% | 8.1% | 6.1% | 5.5% | 7.1% | |||
Net margin, % | ? | -0.5% | 3.9% | 2.8% | 0.9% | -0.2% | 1.7% | |||
FCF yield, % | ? | 18.2% | 15.5% | 2.2% | 12.5% | -55.3% | -27.3% | |||
ROE, % | ? | -2.6% | 17.9% | 12.3% | 3.6% | -0.7% | 9.5% | |||
ROA, % | ? | -0.7% | 7.0% | 4.7% | 1.4% | -0.2% | 2.9% | |||
P/E | ? | -44.5 | 7.35 | 7.14 | 16.5 | -83.6 | 9.25 | |||
P/FCF | 5.49 | 6.46 | 46.4 | 7.98 | -1.81 | -3.67 | ||||
P/S | ? | 0.22 | 0.29 | 0.20 | 0.15 | 0.13 | 0.16 | |||
P/BV | ? | 1.20 | 1.35 | 0.90 | 0.62 | 0.61 | 0.88 | |||
EV/EBITDA | ? | 5.03 | 4.72 | 3.89 | 4.05 | 5.16 | 3.90 | |||
Debt/EBITDA | 2.27 | 1.45 | 1.40 | 1.60 | 2.84 | 1.69 | ||||
Employees, people | 48 391 | 51 832 | 52 857 | 75 000 | ||||||
Labour productivity, mln rub/person/year | 8.63 | 8.60 | 9.15 | 8.21 | ||||||
Expenses per employee, thousand rub | 581.1 | 603.2 | 670.4 | 642.7 | ||||||
R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
CAPEX/Revenue, % | 3% | 2% | 6% | 2% | 2% | 2% | ||||
IR rating | 5.0 | 5.0 | ||||||||
Financial statement quality | 5 | 5 | ||||||||
Investor Presentations | 5 | 5 | ||||||||
Smart-lab presence | 5 | 5 | 5 | |||||||
Annual report | 5 | 5 | ||||||||
Investor site URL | 5 | 5 | 5 | |||||||
Investor calendar | 5 | 5 | ||||||||
IR feedback | 5 | 5 | 5 | |||||||
IPJSC Lenta dr shareholders |